首页> 外文期刊>ACS medicinal chemistry letters >DL5050, a Selective Agonist for the Human Constitutive Androstane Receptor
【24h】

DL5050, a Selective Agonist for the Human Constitutive Androstane Receptor

机译:DL5050,人组成型androstane受体的选择性激动剂

获取原文
获取原文并翻译 | 示例
           

摘要

The constitutive androstane receptor (CAR) is a xenobiotic sensor governing the transcription of genes involved in drug disposition, energy homeostasis, and cell proliferation. However, currently available human CAR (hCAR) agonists are nonselective, which commonly activate hCAR along with other nuclear receptors, especially the closely related human pregnane X receptor (hPXR). Using a well-known hCAR agonist CITCO as a template, we report our efforts in the discovery of a potent and highly selective hCAR agonist. Two of the new compounds of the series, 18 and 19 (DL5050), demonstrated excellent potency and selectivity for hCAR over hPXR. DL5050 preferentially induced the expression of CYP2B6 (target of hCAR) over CYP3A4 (target of hPXR) on both the mRNA and protein levels. The selective hCAR agonist DL5050 represents a valuable tool molecule to further define the biological functions of hCAR, and may also be used as a new lead in the discovery of hCAR agonists for various therapeutic applications.
机译:组成型和rostane受体(轿车)是一种癫痫菌传感器,用于转录参与药物处理,能量稳态和细胞增殖的基因的转录。然而,目前可用的人类汽车(HCAR)激动剂是非选择性的,其通常激活HCAR以及其他核受体,特别是密切相关的人孕X受体(HPXR)。使用着名的HCAR Agonist Citco作为模板,我们向发现有效和高度选择性的HCAR激动剂的努力报告了我们的努力。该系列,18和19(DL5050)中的两种新化合物,在HPXR上表现出优异的HCAR效力和选择性。 DL5050优先诱导CYP2B6(HPXR靶标的HPXR靶标)的表达在MRNA和蛋白质水平上。选择性HCAR激动剂DL5050表示有价值的工具分子,以进一步定义HCAR的生物学功能,也可以用作发现HCAR激动剂的新铅,以进行各种治疗应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号